{"id":748,"date":"2020-01-29T10:47:57","date_gmt":"2020-01-29T10:47:57","guid":{"rendered":"https:\/\/beta.farmakologiportalen.no\/?post_type=fagstoff2&#038;p=748"},"modified":"2023-11-27T18:12:52","modified_gmt":"2023-11-27T18:12:52","slug":"legemiddelmetabolitter-nytteverdi-av-monitorering","status":"publish","type":"fagstoff","link":"https:\/\/beta.farmakologiportalen.no\/fagstoff\/legemiddelmetabolitter-nytteverdi-av-monitorering","title":{"rendered":"Legemiddelmetabolitter &#8211; nytteverdi av monitorering"},"content":{"rendered":"\n<p>Artikkelen er under utarbeiding. Temaet omhandler medbestemmelse av legemiddelmetabolitter i forbindelse med TDM<a><\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Generell tekst<\/h2>\n\n\n\n<p><em>Tekst kommer<\/em><a><\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Eksempler<\/h2>\n\n\n\n<p><em>Tekst kommer<\/em><a><\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/farmakologiportalen.no\/content\/619\/Karbamazepin-farmakologiportalen\">Karbamazepin<\/a><\/h3>\n\n\n\n<p><a href=\"https:\/\/farmakologiportalen.no\/wp-content\/uploads\/2023\/07\/Ma-ling-av-karbamazepin-og-epoksidmetabolitten.pdf\">Lenke til utfyllende dokument<\/a>, skrevet av Cecilie Johannessen Landmark og Svein Johannessen (sist oppdatert 4.desember 2018).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Artikkelen er under utarbeiding. Temaet omhandler medbestemmelse av legemiddelmetabolitter i  [&#8230;]<\/p>\n","protected":false},"author":2,"featured_media":0,"menu_order":0,"template":"","meta":{"footnotes":""},"categories":[23,28],"class_list":["post-748","fagstoff","type-fagstoff","status-publish","hentry","category-faglig-veiledning","category-legemidler"],"_links":{"self":[{"href":"https:\/\/beta.farmakologiportalen.no\/index.php?rest_route=\/wp\/v2\/fagstoff\/748","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beta.farmakologiportalen.no\/index.php?rest_route=\/wp\/v2\/fagstoff"}],"about":[{"href":"https:\/\/beta.farmakologiportalen.no\/index.php?rest_route=\/wp\/v2\/types\/fagstoff"}],"author":[{"embeddable":true,"href":"https:\/\/beta.farmakologiportalen.no\/index.php?rest_route=\/wp\/v2\/users\/2"}],"version-history":[{"count":2,"href":"https:\/\/beta.farmakologiportalen.no\/index.php?rest_route=\/wp\/v2\/fagstoff\/748\/revisions"}],"predecessor-version":[{"id":1184,"href":"https:\/\/beta.farmakologiportalen.no\/index.php?rest_route=\/wp\/v2\/fagstoff\/748\/revisions\/1184"}],"wp:attachment":[{"href":"https:\/\/beta.farmakologiportalen.no\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=748"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/beta.farmakologiportalen.no\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=748"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}